These are the stocks posting the largest moves in premarket trading.
Trump says ‘stupid’ Powell ‘probably won’t cut’ rates when Fed meeting ends Wednesday
In the latest in a series of attacks on Powell, Trump said the Fed’s key borrowing rate should be at least 2 percentage points lower.
Klarna CEO wants to turn the platform into a ‘super app’ with help from AI
The buy now, pay later giant’s IPO may be on hold — but its business strategy remains the same, according to CEO Sebastian Siemiatkowski.
Klarna CEO wants to turn the platform into a ‘super app’ with AI
The buy now, pay later giant’s IPO may be on hold — but its business strategy remains the same, according to CEO Sebastian Siemiatkowski.
JPMorgan Chase unveils new Sapphire Reserve card perks and $795 annual fee
JPMorgan, the biggest U.S. bank by assets, shook up the card industry with the launch of the Sapphire Reserve almost a decade ago.
Nasdaq-traded Chinese herb stock with no revenues rallies 59,000% to top Lululemon in market value
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 59,000% year to date.
Nasdaq-traded Chinese herb stock with no revenues rallies 59,000% to top Lululemon in market value
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 59,000% year to date.
Nasdaq-traded Chinese herb stock with no revenues rallies 59,000% to top Lululemon in market value
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 59,000% year to date.
Nasdaq-traded Chinese herb stock with no revenues rallies 59,000% to top Lululemon in market value
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 59,000% year to date.
Nasdaq-traded Chinese herb stock with no revenues rallies 59,000% to top Lululemon in market value
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 59,000% year to date.